4.7 Article

Evaluating Osteogenic Differentiation of Osteoblastic Precursors Upon Intermittent Administration of PTH/IGFBP7

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Teriparatide Did Not Increase Adult Osteosarcoma Incidence in a 15-Year US Postmarketing Surveillance Study

Alicia Gilsenan et al.

Summary: The Osteosarcoma Surveillance Study in the US from 2003 to 2016 did not find a significant association between teriparatide treatment and osteosarcoma, with the incidence rate aligning with the background rate. Interviewed patients had similar characteristics to non-interviewed patients, and the prevalence of risk factors like radiation history and Paget's disease was low in the osteosarcoma cohort.

JOURNAL OF BONE AND MINERAL RESEARCH (2021)

Review Pharmacology & Pharmacy

Parathyroid hormone and its related peptides in bone metabolism

Tianhong Chen et al.

Summary: Parathyroid hormone (PTH) regulates bone metabolism by binding to PTH1R, promoting both bone formation and bone resorption. Developing improved PTH-related peptides may address the shortcomings of teriparatide.

BIOCHEMICAL PHARMACOLOGY (2021)

Article Orthopedics

Vertebral Collapse Prevented Following Teriparatide Treatment in Postmenopausal Kummell's Disease Patients with Severe Osteoporosis

Peng-guo Gou et al.

Summary: In postmenopausal single-level Kummell's disease patients, conservative treatment with teriparatide was more effective than alendronate in preventing progressive vertebral collapse. Teriparatide promoted mineralized bone formation, reduced kyphosis angle, and increased anterior and posterior border heights and spinal canal diameter compared to alendronate.

ORTHOPAEDIC SURGERY (2021)

Article Cell & Tissue Engineering

Reprogramming of human fibroblasts into osteoblasts by insulin-like growth factor-binding protein 7

ZuFu Lu et al.

STEM CELLS TRANSLATIONAL MEDICINE (2020)

Review Medicine, Research & Experimental

Type H blood vessels in bone modeling and remodeling

Yi Peng et al.

THERANOSTICS (2020)

Article Medicine, Research & Experimental

Regulation of Bone Remodeling by Parathyroid Hormone

Marc N. Wein et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Article Cell Biology

The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling

Fabiana Csukasi et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Review Endocrinology & Metabolism

Use of bone turnover markers in postmenopausal osteoporosis

Richard Eastell et al.

LANCET DIABETES & ENDOCRINOLOGY (2017)

Article Oncology

IGFBP7 Deletion Promotes Hepatocellular Carcinoma

Maaged Akiel et al.

CANCER RESEARCH (2017)

Article Dentistry, Oral Surgery & Medicine

Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study

Aydin Keskinruzgar et al.

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2016)

Article Medicine, General & Internal

Postmenopausal Osteoporosis

Dennis M. Black et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Endocrinology & Metabolism

Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells

S. K. Baniwal et al.

OSTEOPOROSIS INTERNATIONAL (2012)

Article Medicine, General & Internal

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

RM Neer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Cell Biology

Distribution of IGFBP-rP1 in normal human tissues

A Degeorges et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)